Collagen Peptide Supplements Reduce Exercise-Related Knee Pain in Young Active Adults

What the researchers found

Participants taking collagen peptides experienced a 21.9 mm reduction on the Visual Analog Scale (VAS) for exercise-induced knee pain, compared to 15.6 mm for placebo (p = 0.024). Physician evaluations showed an even clearer difference: 23.0 mm reduction versus 14.6 mm (p = 0.003).

Pain at rest and after performing 20 squats did not differ significantly between groups, but this was largely because few participants had pain under those conditions at baseline. Joint mobility was clinically unremarkable at the start and remained unchanged.

Why it matters

Exercise-related joint discomfort is extremely common in active young adults, yet most joint health research focuses on older populations with arthritis. This confirmatory trial shows that a simple, affordable collagen peptide supplement can meaningfully reduce activity-related knee pain in otherwise healthy young people — a population that typically has few options beyond rest and anti-inflammatory drugs.

How the study worked

This was a randomized, double-blind, placebo-controlled trial. 180 physically active men and women aged 18–30 with exercise-related knee pain but no diagnosed joint disease were randomly assigned to receive either 5 grams of specific type I collagen peptides (mean molecular weight 3 kDa) or placebo daily for 12 weeks. Pain was measured using the Visual Analog Scale (VAS) both by participants and examining physicians. Secondary outcomes included pain at rest, pain after squats, knee mobility, and use of alternative therapies.

What this study cannot tell us

The pain reduction, while statistically significant, was modest in absolute terms (about 6 mm difference on a 100 mm VAS scale). The study was funded by a collagen peptide manufacturer (GELITA AG), and one author is a company employee. The 12-week duration doesn't reveal whether benefits persist long-term. Only activity-related pain was significantly affected — resting pain and joint mobility showed no benefit.

How to read the evidence

This is a well-designed randomized, double-blind, placebo-controlled trial with 180 participants — a decent sample size for a supplement study. It was specifically designed to confirm earlier positive findings, adding replication value. However, industry funding and modest effect sizes warrant some caution.

When this study was published

Published in 2021 in Nutrients. The findings remain relevant as collagen peptide supplementation continues to be widely marketed and used.

The bigger picture

Collagen peptide supplementation has gained significant commercial popularity, but clinical evidence has been mixed. This study is notable because it was designed as a confirmatory trial — replicating earlier positive findings in a similar population. Successful replication strengthens the case that these specific collagen peptides have a real, if modest, effect on exercise-related joint pain in young adults.

Questions still open

• Would the benefits persist beyond 12 weeks or increase with longer supplementation?
• Do these collagen peptides actually improve cartilage structure, or do they primarily reduce pain perception?
• Would higher doses produce a larger effect, or is 5 grams the optimal amount?

Common questions

Read the original research

The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial.

Nutrients, 13(2)

Citation

Zdzieblik, Denise; Brame, Judith; Oesser, Steffen; Gollhofer, Albert; König, Daniel. (2021). The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial.. Nutrients, 13(2). https://doi.org/10.3390/nu13020523